2
|
Duan P, Lan X, Chen Y, Qian SS, Li JJ, Lu L, Lu Y, Chen B, Hong M, Zhao J. Rhodium(iii)-catalyzed C–H activation/[4+3] annulation of N-phenoxyacetamides and α,β-unsaturated aldehydes: an efficient route to 1,2-oxazepines at room temperature. Chem Commun (Camb) 2014; 50:12135-8. [DOI: 10.1039/c4cc05485g] [Citation(s) in RCA: 64] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Rhodium-catalyzed C–H bond functionalization led to a [4+3] annulation strategy to access 1,2-oxazepine rings.
Collapse
Affiliation(s)
- Pingping Duan
- Shenzhen Key Lab of Nano-Micro Material Research
- School of Chemical Biology and Biotechnology
- Shenzhen Graduate School of Peking University
- Shenzhen, China
| | - Xia Lan
- Shenzhen Key Lab of Nano-Micro Material Research
- School of Chemical Biology and Biotechnology
- Shenzhen Graduate School of Peking University
- Shenzhen, China
| | - Ying Chen
- Shenzhen Key Lab of Nano-Micro Material Research
- School of Chemical Biology and Biotechnology
- Shenzhen Graduate School of Peking University
- Shenzhen, China
| | - Shao-Song Qian
- School of Life Sciences
- Shandong University of Technology
- Zibo 255049, China
| | - Jie Jack Li
- Department of Chemistry
- University of San Francisco
- San Francisco 94117-1080, USA
| | - Liang Lu
- State Key Laboratory of Pharmaceutical Biotechnology
- School of Life Sciences
- Institute of Chemistry and BioMedical Sciences
- Nanjing University
- Nanjing, China
| | - Yanbo Lu
- Shenzhen Key Lab of Nano-Micro Material Research
- School of Chemical Biology and Biotechnology
- Shenzhen Graduate School of Peking University
- Shenzhen, China
| | - Bo Chen
- Shenzhen Key Lab of Nano-Micro Material Research
- School of Chemical Biology and Biotechnology
- Shenzhen Graduate School of Peking University
- Shenzhen, China
| | - Mei Hong
- Shenzhen Key Lab of Nano-Micro Material Research
- School of Chemical Biology and Biotechnology
- Shenzhen Graduate School of Peking University
- Shenzhen, China
| | - Jing Zhao
- Shenzhen Key Lab of Nano-Micro Material Research
- School of Chemical Biology and Biotechnology
- Shenzhen Graduate School of Peking University
- Shenzhen, China
- State Key Laboratory of Pharmaceutical Biotechnology
| |
Collapse
|
3
|
La Regina G, Bai R, Rensen WM, Di Cesare E, Coluccia A, Piscitelli F, Famiglini V, Reggio A, Nalli M, Pelliccia S, Pozzo ED, Costa B, Granata I, Porta A, Maresca B, Soriani A, Iannitto ML, Santoni A, Li J, Cona MM, Chen F, Ni Y, Brancale A, Dondio G, Vultaggio S, Varasi M, Mercurio C, Martini C, Hamel E, Lavia P, Novellino E, Silvestri R. Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors. J Med Chem 2013; 56:123-49. [PMID: 23214452 PMCID: PMC3563301 DOI: 10.1021/jm3013097] [Citation(s) in RCA: 93] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
New arylthioindole derivatives having different cyclic substituents at position 2 of the indole were synthesized as anticancer agents. Several compounds inhibited tubulin polymerization at submicromolar concentration and inhibited cell growth at low nanomolar concentrations. Compounds 18 and 57 were superior to the previously synthesized 5. Compound 18 was exceptionally potent as an inhibitor of cell growth: it showed IC₅₀ = 1.0 nM in MCF-7 cells, and it was uniformly active in the whole panel of cancer cells and superior to colchicine and combretastatin A-4. Compounds 18, 20, 55, and 57 were notably more potent than vinorelbine, vinblastine, and paclitaxel in the NCI/ADR-RES and Messa/Dx5 cell lines, which overexpress P-glycoprotein. Compounds 18 and 57 showed initial vascular disrupting effects in a tumor model of liver rhabdomyosarcomas at 15 mg/kg intravenous dosage. Derivative 18 showed water solubility and higher metabolic stability than 5 in human liver microsomes.
Collapse
Affiliation(s)
- Giuseppe La Regina
- Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur—Fondazione Cenci Bolognetti, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| | - Ruoli Bai
- Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States
| | - Whilelmina Maria Rensen
- Institute of Molecular Biology and Pathology (IBPM), CNR National Research Council of Italy, c/o Sapienza Università di Roma, Via degli Apuli 4, I-00185 Roma, Italy
| | - Erica Di Cesare
- Institute of Molecular Biology and Pathology (IBPM), CNR National Research Council of Italy, c/o Sapienza Università di Roma, Via degli Apuli 4, I-00185 Roma, Italy
| | - Antonio Coluccia
- Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur—Fondazione Cenci Bolognetti, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| | - Francesco Piscitelli
- Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur—Fondazione Cenci Bolognetti, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| | - Valeria Famiglini
- Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur—Fondazione Cenci Bolognetti, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| | - Alessia Reggio
- Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur—Fondazione Cenci Bolognetti, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| | - Marianna Nalli
- Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur—Fondazione Cenci Bolognetti, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| | - Sveva Pelliccia
- Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli Federico II, Via Domenico Montesano 49, I-80131, Napoli, Italy
| | - Eleonora Da Pozzo
- Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Via Bonanno Pisano 6, I-56126 Pisa, Italy
| | - Barbara Costa
- Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Via Bonanno Pisano 6, I-56126 Pisa, Italy
| | - Ilaria Granata
- Dipartimento di Scienze Farmaceutiche, Sezione Biomedica, Università di Salerno, Via Ponte don Melillo, I-84084 Fisciano, Salerno, Italy
| | - Amalia Porta
- Dipartimento di Scienze Farmaceutiche, Sezione Biomedica, Università di Salerno, Via Ponte don Melillo, I-84084 Fisciano, Salerno, Italy
| | - Bruno Maresca
- Dipartimento di Scienze Farmaceutiche, Sezione Biomedica, Università di Salerno, Via Ponte don Melillo, I-84084 Fisciano, Salerno, Italy
| | - Alessandra Soriani
- Dipartimento di Medicina Sperimentale e Patologia, Sapienza Università di Roma, Viale Regina Elena 324, I-00161 Roma, Italy
| | - Maria Luisa Iannitto
- Dipartimento di Medicina Sperimentale e Patologia, Sapienza Università di Roma, Viale Regina Elena 324, I-00161 Roma, Italy
| | - Angela Santoni
- Institute of Molecular Biology and Pathology (IBPM), CNR National Research Council of Italy, c/o Sapienza Università di Roma, Via degli Apuli 4, I-00185 Roma, Italy
- Dipartimento di Medicina Sperimentale e Patologia, Sapienza Università di Roma, Viale Regina Elena 324, I-00161 Roma, Italy
| | - Junjie Li
- Theragnostic Laboratory, Department of Imaging and Pathology, Faculty of Medicine, Biomedical Sciences Group, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - Marlein Miranda Cona
- Theragnostic Laboratory, Department of Imaging and Pathology, Faculty of Medicine, Biomedical Sciences Group, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - Feng Chen
- Theragnostic Laboratory, Department of Imaging and Pathology, Faculty of Medicine, Biomedical Sciences Group, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - Yicheng Ni
- Theragnostic Laboratory, Department of Imaging and Pathology, Faculty of Medicine, Biomedical Sciences Group, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium
| | - Andrea Brancale
- Welsh School of Pharmacy, Cardiff University, King Edward VII Avenue, Cardiff, CF10 3NB, U.K
| | - Giulio Dondio
- NiKem Research Srl, Via Zambeletti 25, I-20021 Baranzate, Milano, Italy
| | | | - Mario Varasi
- European Institute of Oncology, Via Adamello 16, I-20139 Milano, Italy
| | - Ciro Mercurio
- Genextra Group, DAC SRL, Via Adamello 16, I-20139 Milano, Italy
| | - Claudia Martini
- Department of Psychiatry, Neurobiology, Pharmacology, and Biotechnology, University of Pisa, Via Bonanno Pisano 6, I-56126 Pisa, Italy
| | - Ernest Hamel
- Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, United States
| | - Patrizia Lavia
- Institute of Molecular Biology and Pathology (IBPM), CNR National Research Council of Italy, c/o Sapienza Università di Roma, Via degli Apuli 4, I-00185 Roma, Italy
| | - Ettore Novellino
- Dipartimento di Chimica Farmaceutica e Tossicologica, Università di Napoli Federico II, Via Domenico Montesano 49, I-80131, Napoli, Italy
| | - Romano Silvestri
- Dipartimento di Chimica e Tecnologie del Farmaco, Istituto Pasteur—Fondazione Cenci Bolognetti, Sapienza Università di Roma, Piazzale Aldo Moro 5, I-00185 Roma, Italy
| |
Collapse
|